- Walgreens profits squeezed as Covid vaccine wanes, health-care investment rises CNBC
- Walgreens keeps forecast as waning COVID vaccine demand weighs Reuters
- Walgreens Boots Non-GAAP EPS of $0.96 beats by $0.03, revenue of $32.6B beats by $370M Seeking Alpha
- Walgreens profit plunges on opioid settlement, lower pharmacy sales Yahoo Finance
- Walgreens Boots Alliance Reports Fiscal 2022 Third Quarter Results Business Wire
- View Full Coverage on Google News
Walgreens profits squeezed as Covid vaccine wanes, health-care investment rises – CNBC
